REVA: Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Completed
CT.gov ID
NCT00221715
Collaborator
Ministry of Health, France (Other)
100
2
106

Study Details

Study Description

Brief Summary

When medical treatments fail, critical ischemia of the lower limb often leads to surgery, i.e. above knee femoro popliteal bypass. This bypass can be performed either with DACRON or PTFE prosthesis or with the autologous saphenous vein. Both technics are used but they have not been compared regarding bypass permeability and limb salvage. Thus, this study will compare the permeability rate of above knee femoro popliteal surgery whether performed with autologous vein versus prosthesis

Condition or Disease Intervention/Treatment Phase
  • Device: femoropopliteal artery bypass
  • Device: femoropopliteal artery bypass
N/A

Detailed Description

When medical treatments fail, critical ischemia of the lower limb often leads to surgery, i.e. above knee femoro popliteal bypass. This bypass can be performed with either DACRON or PTFE prosthesis or with the autologous saphenous vein. The principle disadvantages of prosthesis are their prejudged worse permeability and the risk of infection. Too few reliable randomised, multicentric studies in this indication comparing vein bypasses versus prosthesis bypasses have been conducted to firmly confirm the first argument. Thus, the purpose of this multicentric, randomised, national study is to compare, 5 years after surgery, the permeability rate of above knee femoropopliteal bypass with vein versus prosthesis. Primary and secondary permeability, permeability predictive factors, and leg salvage rate will also be assessed. One hundred enrolled patients with II to IV level leg arteritis will randomly be assigned to one of the surgery groups : vein or prosthesis (50 each). The recruiting period will last 3 years and a half, and the follow up 5 years for each patient. The main primary outcome, bypass permeability, will be assessed through Doppler ultrasonography during five years. Secondary endpoints, mortality and morbidity, will be evaluated during the clinical follow up. Permeability predictive factors, primary and secondary permeability, leg salvage will also be recorded. If the permeability rates are equivalent between prosthesis and vein, the use of prosthesis will be preferred as this surgery is easier and faster, and as it is important that the vein remains available for distal revascularisation (where it is more efficient) and for revascularisation of coronary arteries

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Randomised Study Comparing Prosthesis and Autologous Vein for Revascularisation With Above Knee Femoropopliteal Bypass.
Study Start Date :
Jul 1, 2002
Actual Primary Completion Date :
May 1, 2011
Actual Study Completion Date :
May 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

bypass by autologous saphenous vein

Device: femoropopliteal artery bypass
Bypass by autologous saphenous vein

Active Comparator: 2

bypass by dacron or PTFE Prosthesis

Device: femoropopliteal artery bypass
bypass by dacron or PTFE Prosthesis

Outcome Measures

Primary Outcome Measures

  1. Bypass permeability 5 years after surgery, assessed trough Doppler ultrasonography [5 years]

Secondary Outcome Measures

  1. Mortality [5 years]

  2. Morbidity [5 years]

  3. permeability predictive factors (smoking habits, diabetes, hyperlipidemia, bypass diameter) [5 years]

  4. Primary and secondary permeability [5 years]

  5. leg salvage [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • lower limbs arteritis : II to IV arteritis level, above knee femoro popliteal bypass indication

  • signed informed consent

Exclusion Criteria:
  • no contra indication to the use of prosthesis

  • Available saphenous vein

  • no major trophic trouble

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Bordeaux
  • Ministry of Health, France

Investigators

  • Principal Investigator: Dominique Midy, Professor, University Hospital, Bordeaux
  • Study Chair: Geneviève Chêne, Professor, University Hospital, Bordeaux

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT00221715
Other Study ID Numbers:
  • 9248-01
  • 2000-006
First Posted:
Sep 22, 2005
Last Update Posted:
May 9, 2013
Last Verified:
May 1, 2013

Study Results

No Results Posted as of May 9, 2013